Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean

NCT02670057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2017-12-14

No results posted yet for this study

Summary

The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.

Conditions

  • Ipsilateral Shoulder Pain

Interventions

PROCEDURE

Transnasal SPG block

Sponsors & Collaborators

Principal Investigators

  • Gilbert Grant · New York University Medical School

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-12-12
Completion
2017-12-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02670057 on ClinicalTrials.gov